• SIGN IN
  • GET HELP
  •  

    Webinar Details


    Event Type

    Live Online

    Date

    Tuesday, September 19, 2023

    Time

    8:00 PM - 9:00 PM ET

    Location

    PharmCon Webinar Studio (freeCE.com)

    Credits

    1 Contact Hour(s)

    Target Audience

    Pharmacist, Pharmacy Technician, Nurse

    Cost

    $30.00

    • Overview

      While benzodiazepines do not get the same level of drug-harm publicity that opioids do, they still pose a significant public health threat due to medication harm. Despite over 60 years of market availability, much still needs to be learned regarding which patients should be prescribed these medications and when and how they can appropriately be deprescribed. In attending this program, participants will learn both appropriate prescribing and deprescribing techniques. They will also interact with a patient case and learn how to facilitate positive conversations regarding benzodiazepine use and tapering. 


      Handouts

      Slide Document 23144L01_2pp.pdf
      Slide Document 23144L01_6pp.pdf





      Financial Support By

      PharmCon
    • Pharmacist

      Recall prescribing principles for benzodiazepines and understand diazepam mg equivalents (DME) while identifying its usefulness in deprescribing
      Recognize appropriate guidance for prescribing and the systems in place for deprescribing
      Using a case study, cite appropriate steps for tapering and deprescribing
      Recognize elements of effective patient communications in regard to benzodiazepine use and tapering

      Pharmacy Technician

      Recall prescribing principles for benzodiazepines and understand diazepam mg equivalents (DME) while identifying its usefulness in deprescribing
      Recognize appropriate guidance for prescribing and the systems in place for deprescribing
      Using a case study, cite appropriate steps for tapering and deprescribing
      Recognize elements of effective patient communications in regard to benzodiazepine use and tapering

      Nurse

      Recall prescribing principles for benzodiazepines and understand diazepam mg equivalents (DME) while identifying its usefulness in deprescribing
      Recognize appropriate guidance for prescribing and the systems in place for deprescribing
      Using a case study, cite appropriate steps for tapering and deprescribing.
      Recognize elements of effective patient communications in regard to benzodiazepine use and tapering
    • Repeat Presentation

      This presentation was last given on 9/19/2023 8:00 PM

      Future Airings

      There are no future airings of this activity scheduled at this time.

    • Activity Type

      Application

      CE Broker

      20-1036126

      Universal Activity Number

      Pharmacist 0798-0000-23-144-L01-P

      Pharmacy Technician 0798-0000-23-144-L01-T

      Nurse 0798-0000-23-144-L01-N

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, attendees must respond to all randomly-generated participation checks and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.


    HARDWARE REQUIREMENTS
    Windows 8.1
    Windows 10
    Apple Mac OS X 10.13 or higher
    iOS 10+
    Android 4.3+


    SOFTWARE REQUIREMENTS
    Google Chrome
    Mozilla Firefox

    Log in locally; do not log in using a VPN, cloud server, remote desktop, etc.


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon. Through this notice, PharmCon. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).




    Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.